VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Is Obesity Really a Dangerous Disease?
Obesity drugmakers Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , VIVUS, Inc. (NASDAQ:VVUS) , and Orexigen Therapeutics, Inc.
Orexigen Therapeutics Inc (OREX)
Market is closed
News
- First
- << Previous
- 61 - 69
5 Hidden Causes of Obesity: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)
Obesity-drug makers Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS Inc. (NASDAQ:VVUS), and Orexigen Therapeutics, Inc.
Tick Tock Goes the Obesity Clock: Orexigen Therapeutics, Inc. (OREX), VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)
The Food and Drug Administration made the company run a clinical trial to confirm that there weren't any heart-related complications with Contrave.
Is the Wait Over? - Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS), Orexigen Therapeutics, Inc. (OREX)
The obesity industry is new on the stock block, but it has already become one of the most followed industries in our market.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Is There a "First-Mover" Advantage in Biotech?
The early bird gets the worm. Business gurus might not use that old phrase, but many of them tout the principle behind it.
3 Humongous Health-Care Stocks Last Week: Orexigen Therapeutics, Inc. (OREX), Optimer Pharmaceuticals, Inc. (OPTR)
While the overall market seemed to be deciding this week whether to keep the rally going or take a break, several stocks in the world of health care left no doubt.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals Inc. (ARNA): Just 12,500% More Growth for an Obesity Blockbuster
Of course, that's kind of like talking about an huge gnat. I'm sure they probably exist, but you're working from such a small base, that the added size doesn't amount to much.
The FDA Made Biotech Investing Harder (But More Lucrative): Johnson & Johnson (JNJ)
For instance, it's hard to make money on shoo-in Food and Drug Administration approvals. The approval is already reflected in the price.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Will There Ever Be an Obesity Drug Blockbuster?
Investors are anxiously waiting for the launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai's obesity drug Belviq, which will match up with VIVUS, Inc.
- First
- << Previous
- 61 - 69
Billionaire Hedge Funds
